InVivoMAb Anti-Human IGF1 Antibody (TBS10343)

$489.00$2,399.00

Target: IGF-I, IGF1, Mechano growth factor, MGF, Insulin-like growth factor I, IBP1, Somatomedin-C.

SKU: TBS10343 Categories: ,
SKUStock SIZE (mg) PriceQuantity
TBS10343-0.5MG Yes 0.5 MG $489.00
spinner
TBS10343-1MG Yes 1 MG $719.00
spinner
TBS10343-5MG Yes 5 MG $2,399.00
spinner

Description

InVivoMAb Anti-Human IGF-1 antibody is a monoclonal antibody designed to specifically bind and neutralize human insulin-like growth factor-1 (IGF-1), a key growth factor involved in cell proliferation, survival, and tumor progression. By blocking IGF-1 signaling, this antibody is widely used in in vivo and translational research to inhibit IGF-1–mediated cancer cell growth and proliferation, investigate IGF-driven oncogenic pathways, and evaluate therapeutic strategies targeting the IGF axis in cancer and other IGF-1–related diseases.

Synonyms: Anti-Human IGF-1 monoclonal antibody, Anti-IGF-1 antibody, IGF-1 neutralizing antibody, IGF-1–specific mAb, In-vivo anti-IGF-1 antibody, Neutralizing anti-IGF-1 mAb.

Product Details

Applications: ELISA, FCM, Neutralization
Species reactivity: Human
Host: Human
Isotype: IgG1, lambda
Target: IGF-I, IGF1, Mechano growth factor, MGF, Insulin-like growth factor I, IBP1, Somatomedin-C.
Uniprot: P05019
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4.
Purification: Protein A/G purified from cell culture supernatant.
Clonality: Monoclonal
Storage: Store -20°C up to 12 months, and -80°C for long term. Avoid repeated freeze-thaw cycles.

Data Image

Fig. 1. SDS-PAGE for InVivoMAb Anti-Human IGF1.

MW: Molecular Weight (kDa) Marker.

R: Reducing conditions.

NR: Non-Reducing conditions.

 

Fig. 2. SEC-HPLC detection for InVivoMAb Anti-Human IGF1 

Fig. 3. Flow-cytometry using anti-human IGF2 antibody. HepG2 cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human IGF2 antibody monoclonal antibody (Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-human antibody and cells analyzed on a NovoCyte Flow Cytometer.

Fig. 4. Flow-cytometry using anti-human IGF1 antibody. Human Jurkat cell line were stained with an irrelevant antibody (Blue Histogram) or an anti-human IGF1 antibody monoclonal antibody (Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-human antibody and cells analyzed on a NovoCyte Flow Cytometer.

Fig. 5. Flow-cytometry using anti-human IGF2 antibody. A549 cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human IGF2 antibody monoclonal antibody (Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-human antibody and cells analysed on a NovoCyte Flow Cytometer.

Fig. 6. Flow-cytometry using anti-human IGF1 antibody. HeLa cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human IGF1 antibody monoclonal antibody (Green Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a FITC conjugated goat anti-human antibody and cells analysed on a NovoCyte Flow Cytometer.

Research use only.

Additional information

SIZE (mg)

1 MG, 5 MG, 0.5 MG

Reviews

There are no reviews yet.


Be the first to review “InVivoMAb Anti-Human IGF1 Antibody (TBS10343)”